Acuta Capital Partners, Llc
Source: SEC Form 13F · as of Mar 2026Acuta Capital Partners, Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $85.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$85.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Terns Pharmaceuticals, Inc. (TERN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TERNTerns Pharmaceuticals, Inc. | 495,772 | $26.1M |
| WHWKWhitehawk Therapeutics, Inc. | 3,410,402 | $11.8M |
| TNGXTango Therapeutics, Inc. | 441,831 | $9.2M |
| STROSUTRO BIOPHARMA, INC. | 269,425 | $6.7M |
| SRZNSurrozen Inc. | 172,847 | $5.0M |
| OCULOCULAR THERAPEUTIX, INC | 592,108 | $5.0M |
| CMPXCompass Therapeutics, Inc. | 849,076 | $4.5M |
| MLTXMoonLake Immunotherapeutics | 191,760 | $3.6M |
| ARGXARGENX SE | 4,690 | $3.4M |
| OCSOculis Holding AG | 98,339 | $2.6M |
| RVMDREVOLUTION MEDICINES, INC. | 26,069 | $2.5M |
| DSGNDesign Therapeutics, Inc. | 145,900 | $1.6M |
| TRDAEntrada Therapeutics, Inc. | 89,358 | $1.1M |
| AVTXAvalo Therapeutics, Inc. | 60,808 | $908K |
| LBRXLB PHARMACEUTICALS INC | 28,919 | $713K |
| MAZEMaze Therapeutics, Inc. | 19,335 | $577K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.